Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ed Ajootian who wrote (960)	7/5/1998 1:08:00 PM
From: Biomaven	Read Replies (1) of 10280

Ed, My recollection is that Dan refused to believe the SEPR trials that showed lung function after long term albuterol use was worse than a placebo, and much worse than levalbuterol. Hence the importance of the new trial SEPR is running to attempt to demonstrate conclusively that levalbuterol's advantage over albuterol is not just fewer immediate side-effects but also long-term improved lung function. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next